ABOUT INDEXING BOARD ARCHIVES AUTHOR GUIDELINES SUBMIT PAPER AUTHOR'S PAGE NEWS, EVENTS CONTACT
REVISTA DE CHIMIE
Cite as: Rev. Chim.
https://doi.org/10.37358/Rev.Chim.1949

OSIM Nr. R102355
ISSN Online 2668-8212
ISSN Print: 1582-9049
ISSN-L: 1582-9049

REVISTA DE CHIMIE Latest Issue

LATEST ISSUE >>>

   Volume 75, 2024
   Volume 74, 2023
   Volume 73, 2022
   Volume 72, 2021
   Volume 71, 2020
   Volume 70, 2019
   Volume 69, 2018
   Volume 68, 2017
   Volume 67, 2016
   Volume 66, 2015
   Volume 65, 2014
   Volume 64, 2013
   Volume 63, 2012
   Volume 62, 2011
   Volume 61, 2010
   Volume 60, 2009
   Volume 59, 2008
   Volume 58, 2007
 
<<<< back

Revista de Chimie (Rev. Chim.), Year 2017, Volume 68, Issue 7, 1557-1559

https://doi.org/10.37358/RC.17.7.5715

Andra Buruiana, Nicoleta Dumitru, Adina Ghemigian, Eugenia Nedeltcheva Petrova

Genetic Testing in Differentiated Thyroid Carcinoma - Important or Not?

Abstract:

Thyroid carcinoma is the most common endocrine cancer representing 1-1.5% of all cancers diagnosed annually. Differentiated thyroid carcinoma (DTC) with the 2 main subtypes, papillary (PTC) and follicular (FTC), is the most common. DTC incidence has increased significantly in recent years, mainly due to increased and early use of imaging techniques (thyroid ultrasonography) and fine needle biopsy of thyroid nodules. Although after radical treatment, DTC is considered to be curable, histologic and clinical presentation is very diverse, the recurrence rate being 10-30%, while 5% of patients are resistant to conventional therapy, and some are even incurable. In recent years, there has been progress in terms of describing genetic changes in thyroid carcinoma, genetic testing providing important information that may influence therapeutic decision. The practical importance of these genetic mutations (for example, BRAF V600E, RAS, etc.) and their roles in tumorigenesis, the clinical features, treatment and prognosis of thyroid carcinoma is still controversial and incompletely elucidated.The increase knowledge of molecular pathogenesis and tumorigenesis in thyroid cancer lead to the emergence of new therapies with targeted antitumor effect and minimal toxicity. Patient selection should be made taking into account the risk stratification and tangible benefits, molecular tests being expensive and inaccessible.
Keywords:
differentiated thyroid carcinoma; genetic mutations; BRAF V600E

Issue: 2017, Volume 68, Issue 7
Pages: 1557-1559
Publication date: 2017/8/15
https://doi.org/10.37358/RC.17.7.5715
download pdf   Download Pdf Article
Creative Commons License
This article is published under the Creative Commons Attribution 4.0 International License
Citation Styles
Cite this article as:
BURUIANA, A., DUMITRU, N., GHEMIGIAN, A., PETROVA, E.N., Genetic Testing in Differentiated Thyroid Carcinoma - Important or Not?, Rev. Chim., 68(7), 2017, 1557-1559.

Vancouver
Buruiana A, Dumitru N, Ghemigian A, Petrova EN. Genetic Testing in Differentiated Thyroid Carcinoma - Important or Not?. Rev. Chim.[internet]. 2017 Jul;68(7):1557-1559. Available from: https://doi.org/10.37358/RC.17.7.5715


APA 6th edition
Buruiana, A., Dumitru, N., Ghemigian, A. & Petrova, E.N. (2017). Genetic Testing in Differentiated Thyroid Carcinoma - Important or Not?. Revista de Chimie, 68(7), 1557-1559. https://doi.org/10.37358/RC.17.7.5715


Harvard
Buruiana, A., Dumitru, N., Ghemigian, A., Petrova, E.N. (2017). 'Genetic Testing in Differentiated Thyroid Carcinoma - Important or Not?', Revista de Chimie, 68(7), pp. 1557-1559. https://doi.org/10.37358/RC.17.7.5715


IEEE
A. Buruiana, N. Dumitru, A. Ghemigian, E.N. Petrova, "Genetic Testing in Differentiated Thyroid Carcinoma - Important or Not?". Revista de Chimie, vol. 68, no. 7, pp. 1557-1559, 2017. [online]. https://doi.org/10.37358/RC.17.7.5715


Text
Andra Buruiana, Nicoleta Dumitru, Adina Ghemigian, Eugenia Nedeltcheva Petrova,
Genetic Testing in Differentiated Thyroid Carcinoma - Important or Not?,
Revista de Chimie,
Volume 68, Issue 7,
2017,
Pages 1557-1559,
ISSN 2668-8212,
https://doi.org/10.37358/RC.17.7.5715.
(https://revistadechimie.ro/Articles.asp?ID=5715)
Keywords: differentiated thyroid carcinoma; genetic mutations; BRAF V600E


RIS
TY - JOUR
T1 - Genetic Testing in Differentiated Thyroid Carcinoma - Important or Not?
A1 - Buruiana, Andra
A2 - Dumitru, Nicoleta
A3 - Ghemigian, Adina
A4 - Petrova, Eugenia Nedeltcheva
JF - Revista de Chimie
JO - Rev. Chim.
PB - Revista de Chimie SRL
SN - 2668-8212
Y1 - 2017
VL - 68
IS - 7
SP - 1557
EP - 1559
UR - https://doi.org/10.37358/RC.17.7.5715
KW - differentiated thyroid carcinoma
KW - genetic mutations
KW - BRAF V600E
ER -


BibTex
@article{RevCh2017P1557,
author = {Buruiana Andra and Dumitru Nicoleta and Ghemigian Adina and Petrova Eugenia Nedeltcheva},
title = {Genetic Testing in Differentiated Thyroid Carcinoma - Important or Not?},
journal = {Revista de Chimie},
volume = {68},
number = {7},
pages = {1557-1559},
year = {2017},
issn = {2668-8212},
doi = {https://doi.org/10.37358/RC.17.7.5715},
url = {https://revistadechimie.ro/Articles.asp?ID=5715}
}
 
<<<< back
 
PUBLISHING SECTION
Author Guidelines
 * Paper Drafting
 * Paper Template
 * Ethical Statement
 * Paper Submission
Ghidul Autorului (ro)
Submit Paper
Author's Page
Publishing Ethics
Peer Review Process
Open Access & Archiving Policy
 Search Authors
 LATEST NEWS
REvista de Chimie NUMAR OMAGIAL PETRU PONI.. detalii
REvista de Chimie Revista de Chimie - 70 de ani de aparitie neintrerupta.. detalii
dictionar English-Romanian Dictionary for Mechanical Engineering
(download pdf)
  News, Events
Crossref Member Badge
 DOI  logo
 Gold Open Access | Source=http://www.plos.org/  | Author=art designer at PLoS
Creative Commons License
 Conferences of Contemporary
 Chemistry
 Biblioteca Chimiei
 Materiale Plastice